Amino Acids

, Volume 33, Issue 2, pp 261–265 | Cite as

Polyamine analogues – an update

  • H. M. Wallace
  • K. Niiranen
Minireview Article

Summary.

The polyamines are growth factors in both normal and cancer cells. As the intracellular polyamine content correlates positively with the growth potential of that cell, the idea that depletion of polyamine content will result in inhibition of cell growth and, particularly tumour cell growth, has been developed over the last 15 years. The polyamine pathway is therefore a target for development of rationally designed, antiproliferative agents. Following the lessons from the single enzyme inhibitors (α-difluoromethylornithine DFMO), three generations of polyamine analogues have been synthesised and tested in vitro and in vivo. The analogues are multi-site inhibitors affecting multiple reactions in the pathway and thus prevent the up-regulation of compensatory reactions that have been the downfall of DFMO in anticancer chemotherapy. Although the initial concept was that the analogues may provide novel anticancer drugs, it now seems likely that the analogues will have wider applications in diseases involving hyperplasia.

Keywords: Cancer – Spermidine – Spermine – Polyamine analogues – DFMO – Disease 

Abbreviations:

AOE-PU

N-[2-aminooxyethyl]-1,4-diaminobutane

APA

1-aminooxy-3-aminopropane

AP-APA

1-aminooxy-3-N-[3-aminopropyl]-aminopropane

BCNU

1,3-bis(2-chloroethyl)-1-nitrosourea

BEHSpm/DEHSpm/BE-4-4-4

N 1,N 14-bis(ethyl)-homospermine

BENSpm/DENSpm/BE-3-3-3

N 1,N 11-bis(ethyl)-norspermine

BES

N 1,N 8-bis(ethyl)spermidine

BESpm/DESpm/BE-3-4-3

N 1,N 12-bis(ethyl)spermine

CHENSpm

N 1-ethyl-N 11-((cycloheptyl)methyl)-4,8-diazaundecane

CPENSpm

N 1-ethyl-N 11-((cyclopropyl)methyl)-4,8-diazaundecane

DFMO

α-difluoromethylornithine

IPENSpm

N 1-ethyl-N 11-((isopropyl)methyl)-4,8-diazaundecane

MGBG

methylglyoxal bis(guanylhydrazone)

ODC

ornithine decarboxylase

SAMDC

S-adenosylmethionine decarboxylase

SSAT

spermidine/spermine N 1-acetyltransferase

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alhonen, L, Parkkinen, JJ, Keinänen, T, Sinervirta, R, Herzig, KH, Jänne, J 2000Activation of polyamine catabolism in transgenic rats induces acute pancreatitisProc Natl Acad Sci USA9782908295PubMedCrossRefGoogle Scholar
  2. Alhonen-Hongisto, L, Seppänen, P, Jänne, J 1980Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis(guanylhydrazone)Biochem J192941945PubMedGoogle Scholar
  3. Bellevue, FH,III, Boahbedason, M, Wu, R, Woster, PM, Casero, RA,Jr, Rattendi, D, Lane, S, Bacchi, CJ 1996Structural comparison of alkylpolyamine analogues with potent in vitro antitumor or antiparasitic activityBioorg Med Chem Lett627652770CrossRefGoogle Scholar
  4. Bergeron, RJ, Neims, AH, McManis, JS, Hawthorne, TR, Vinson, JR, Bortell, R, Ingeno, MJ 1988Synthetic polyamine analogues as antineoplasticsJ Med Chem3111831190PubMedCrossRefGoogle Scholar
  5. Bernacki, RJ, Bergeron, RJ, Porter, CW 1992Antitumor activity of N,N′-bis(ethyl)spermine homologues against human MALME-3 melanoma xenograftsCancer Res5224242430PubMedGoogle Scholar
  6. Casero, RA,Jr, Ervin, SJ, Celano, P, Baylin, SB, Bergeron, RJ 1989Differential response to treatment with the bis(ethyl)polyamine analogues between human small cell lung carcinoma and undifferentiated large cell lung carcinoma in cultureCancer Res49639643PubMedGoogle Scholar
  7. Casero, RA,Jr, Go, B, Theiss, HW, Smith, J, Baylin, SB, Luk, GD 1987Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N 1,N 8-bis(ethyl)spermidineCancer Res4739643967PubMedGoogle Scholar
  8. Casero, RA,Jr, Mank, AR, Saab, NH, Wu, R, Dyer, WJ, Woster, PM 1995Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells 1Cancer Chemother Pharmacol366974PubMedGoogle Scholar
  9. Chang, BK, Bergeron, RJ, Porter, CW, Vinson, JR, Liang, Y, Libby, PR 1992Regulatory and antiproliferative effects of N-alkylated polyamine analogues in human and hamster pancreatic adenocarcinoma cell linesCancer Chemother Pharmacol30183188PubMedCrossRefGoogle Scholar
  10. Eloranta, TO, Khomutov, AR, Khomutov, RM, Hyvönen, T 1990Aminooxy analogues of spermidine as inhibitors of spermine synthase and substrates of hepatic polyamine acetylating activityJ Biochem (Tokyo)108593598Google Scholar
  11. Fraser, AV, Woster, PM, Wallace, HM 2002Induction of apoptosis in human leukaemic cells by IPENSpm, a novel polyamine analogue and anti-metaboliteBiochem J367307312PubMedCrossRefGoogle Scholar
  12. French, FA, Freedlander, BL, Hasking, A, French, J 1960Carcinostatic activity of some dicarbonyl compounds and their bis-hydrazonesActa Unio Int Contra Cancrum16614624PubMedGoogle Scholar
  13. Hahm, HA, Ettinger, DS, Bowling, K, Hoker, B, Chen, TL, Zabelina, Y, Casero, RA,Jr 2002Phase I study of N 1,N 11-diethylnorspermine in patients with non-small cell lung cancerClin Cancer Res8684690PubMedGoogle Scholar
  14. Jänne, J, Pösö, H, Raina, A 1978Polyamines in rapid growth and cancerBiochim Biophys Acta473241293PubMedGoogle Scholar
  15. Järvinen, A, Grikorenko, N, Khomutov, AR, Hyvönen, MT, Uimari, A, Vepsäläinen, J, Sinervirta, R, Keinänen, TA, Vujcic, S, Alhonen, L, Porter, CW, Jänne, J 2005Metabolic stability of alpha-methylated polyamine derivatives and their use as substitutes for the natural polyaminesJ Biol Chem28065956601PubMedCrossRefGoogle Scholar
  16. Khomutov, AR, Grigorenko, NA, Skuridin, AG 2007Novel approach to design isosteric charge-deficient analogue of spermine and its biochemical important derivativesBiochem Soc Trans35369373PubMedCrossRefGoogle Scholar
  17. Levin, VA, Prados, MD, Yung, WK, Gleason, MJ, Ictech, S, Malec, M 1992Treatment of recurrent gliomas with eflornithineJ Natl Cancer Inst8414321437PubMedCrossRefGoogle Scholar
  18. Lin, PK, Pavlov, VA 2000The synthesis and in vitro cytotoxic studies of novel bis-naphthalimidopropyl polyamine derivativesBioorg Med Chem Lett1016091612PubMedCrossRefGoogle Scholar
  19. Mamont, PS, Siat, M, Joder-Ohlenbusch, AM, Bernhardt, A, Casara, P 1984Effects of (2R, 5R)-6-heptyne-2,5-diamine, a potent inhibitor of L-ornithine decarboxylase, on rat hepatoma cells cultured in vitroEur J Biochem142457463PubMedCrossRefGoogle Scholar
  20. Metcalf, BW, Bey, P, Danzin, C, Jung, MJ, Casara, P, Vevert, JP 1978Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogsJ Am Chem Soc10025512553CrossRefGoogle Scholar
  21. Meyskens, F, Gerner, EW 1999Development of α-difluoromethylornithine (DFMO) as a chemopreventative agentClin Cancer Res5945951PubMedGoogle Scholar
  22. Porter, CW, Cavanaugh, PF,Jr, Stolowich, N, Ganis, B, Kelly, E, Bergeron, RJ 1985Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cellsCancer Res4520502057PubMedGoogle Scholar
  23. Porter, CW, Dworaczyk, D, Ganis, B, Weiser, MM 1980Polyamines and biosynthetic enzymes in the rat intestinal mucosa and the influence of methylglyoxal-bis(guanylhydrazone)Cancer Res4023302335PubMedGoogle Scholar
  24. Räsänen, TL, Alhonen, L, Sinervirta, R, Keinänen, T, Herzig, KH, Suppola, S, Khomutov, AR, Vepsäläinen, J, Jänne, J 2002A polyamine analogue prevents acute pancreatitis and restores early liver regeneration in transgenic rats with activated polyamine catabolismJ Biol Chem2773986739872PubMedCrossRefGoogle Scholar
  25. Seiler, N, Atassanov, CL, Raul, F 1998Polyamine metabolism as target for cancer chemoprevention (review)Int J Oncol139931006PubMedGoogle Scholar
  26. Smart, LM, Davidson, RJL, Wallace, HM, Thomson, AW 1989aAnti-leukaemic effects of cyclosporin A alone and in combination with α-difluoromethylornithine in the ratTransplant Proc21954955Google Scholar
  27. Smart, LM, McLachlan, G, Wallace, HM, Thomson, AW 1989bInfluence of cyclosporin A and α-difluoromethylornithine, an inhibitor of polyamine biosynthesis on two rodent T-cell cancers in-vivoInt J Cancer4410691073CrossRefGoogle Scholar
  28. Streiff, RR, Bender, JF 2001Phase 1 study of N 1,N 11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignanciesInvest New Drugs192939PubMedCrossRefGoogle Scholar
  29. Tabor, CW, Tabor, H 1984PolyaminesAnnu Rev Biochem53749790PubMedCrossRefGoogle Scholar
  30. Wallace, HM, Fraser, AF 2003Polyamine analogues as anticancer drugsBiochem Soc Trans31393396PubMedCrossRefGoogle Scholar
  31. Wallace, HM, Fraser, AF 2004Inhibitors of polyamine metabolism: review articleAmino Acids26352365CrossRefGoogle Scholar
  32. Wallace, HM, Fraser, AF, Hughes, A 2003A perspective of polyamine metabolismBiochem J376114PubMedCrossRefGoogle Scholar
  33. Wallace, HM, Mackarel, AJ 1998Regulation of polyamine acetylation and efflux in human cancer cellsBiochem Soc Trans26571575PubMedGoogle Scholar
  34. Wolff, AC, Armstrong, DK, Fetting, JH, Carducci, MK, Riley, CD, Bender, JF, Casero, RA,Jr, Davidson, NE 2003A Phase II study of the polyamine analog N 1,N 11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancerClin Cancer Res959225928PubMedGoogle Scholar
  35. Woster, PM 2006Polyamine structure and synthetic analogsWang, JYCasero, RA,Jr eds. Polyamine cell signalingHumana Press Inc.Totowa324Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • H. M. Wallace
    • 1
  • K. Niiranen
    • 1
  1. 1.Department of Medicine and Therapeutics, School of Medicine and School of Medical SciencesUniversity of AberdeenAberdeenUK

Personalised recommendations